Neighbors singing from balconies above empty Spanish streets, apartment windows filled with people clapping for carers in the UK, a man running a marathon in his living room in China—people living in small homes became ...
Jul 27, 2021
0
3
Boosting the body's own disease-fighting immune pathway could provide answers in the desperate search for new treatments for tuberculosis.
Jul 12, 2021
0
12
A comprehensive health-screening program in rural northern KwaZulu-Natal, South Africa, has found a high burden of undiagnosed or poorly controlled non-communicable diseases, according to a study published in The Lancet Global ...
Jun 18, 2021
0
3
Studying the implementation of public health interventions typically involves the identification of "facilitators" and "barriers." In the case of active tuberculosis case-finding (also referred to as community-based tuberculosis ...
May 28, 2021
0
2
A new study published in Nature Communications provides an important new basis for comparing the effectiveness of different tuberculosis treatments.
May 18, 2021
0
30
Mycobacterium tuberculosis is incredible in that it can survive for decades within its human host. It does this by varying its diet to successfully steal nutrients from the human host including immune cells; it is known to ...
May 12, 2021
0
3
(HealthDay)—A four-month rifapentine-based regimen containing moxifloxacin is noninferior to a standard six-month regimen for treatment of tuberculosis, according to a study published in the May 6 issue of the New England ...
May 6, 2021
0
0
Globally, tuberculosis is the most common bacterial infectious disease leading to death. The pathogen causing tuberculosis, Mycobacterium tuberculosis, has a number of peculiarities. One is that it is growing very slowly. ...
May 3, 2021
0
4
New World Health Organization (WHO) guidelines and handbook on systematic screening for active tuberculosis were published in March 2021. The handbook cites two studies from Ph.D. students Olivia Biermann's doctoral thesis, ...
Apr 20, 2021
0
6
A considerably higher dose of the anti-tuberculosis drug rifampicin is safe and can also lead to a shorter treatment for tuberculosis and less resistance. This is what researchers from Radboud university medical center in ...
Mar 22, 2021
0
2
